$CUTR
CUTERA INC

2019 Form 10-K Financial Statement

#000143774920005342 Filed on March 16, 2020

View on sec.gov

Income Statement

Concept 2019 2018 Q4 2018 Q3
Revenue $181.7M $45.47M $40.57M
YoY Change 11.67% -4.54% 6.29%
Cost Of Revenue $83.55M $26.68M $18.69M
YoY Change 1.47% 31.45% 17.07%
Gross Profit $98.16M $18.79M $21.89M
YoY Change 22.12% -31.27% -1.46%
Gross Profit Margin 54.02% 41.32% 53.94%
Selling, General & Admin $95.14M $20.81M $19.64M
YoY Change 19.8% 7.78% 18.83%
% of Gross Profit 96.92% 110.78% 89.74%
Research & Development $15.09M $3.464M $3.244M
YoY Change 5.06% -0.49% -6.43%
% of Gross Profit 15.37% 18.44% 14.82%
Depreciation & Amortization $1.500M $360.0K $310.0K
YoY Change 24.07% 33.33% 19.23%
% of Gross Profit 1.53% 1.92% 1.42%
Operating Expenses $110.2M $24.28M $22.88M
YoY Change 17.55% 6.52% 43.07%
Operating Profit -$12.06M -$5.490M -$998.0K
YoY Change -9.92% -220.85% -116.06%
Interest Expense -$200.0K -$40.00K -$50.00K
YoY Change 100.0% -128.57% -133.33%
% of Operating Profit
Other Income/Expense, Net -$199.0K -$44.00K -$49.00K
YoY Change 61.79% -131.88% -124.87%
Pretax Income -$12.26M -$5.534M -$1.047M
YoY Change -13.5% -218.22% -116.33%
Income Tax $85.00K $20.76M -$174.0K
% Of Pretax Income
Net Earnings -$12.35M -$26.29M -$873.0K
YoY Change -59.87% -214.92% -114.11%
Net Earnings / Revenue -6.8% -57.83% -2.15%
Basic Earnings Per Share -$0.88 -$1.89 -$0.06
Diluted Earnings Per Share -$0.88 -$1.89 -$0.06
COMMON SHARES
Basic Shares Outstanding 14.10M shares 13.93M 13.85M
Diluted Shares Outstanding 14.10M shares 13.93M 13.85M

Balance Sheet

Concept 2019 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $33.90M $35.60M $26.90M
YoY Change -4.78% -0.84% -46.73%
Cash & Equivalents $26.30M $26.05M $21.87M
Short-Term Investments $7.600M $9.500M $5.000M
Other Short-Term Assets $5.600M $4.000M $3.700M
YoY Change 40.0% 37.93% 27.59%
Inventory $33.90M $28.01M $31.32M
Prepaid Expenses
Receivables $21.60M $19.64M $25.44M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $95.00M $87.20M $87.37M
YoY Change 8.94% -1.33% -9.65%
LONG-TERM ASSETS
Property, Plant & Equipment $10.50M $2.672M $2.784M
YoY Change 288.89% 27.48% 51.14%
Goodwill $1.339M $1.339M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.800M $5.971M $6.048M
YoY Change 6.25% 1496.52% 1487.4%
Total Long-Term Assets $18.70M $10.44M $31.57M
YoY Change 79.81% -54.34% 700.13%
TOTAL ASSETS
Total Short-Term Assets $95.00M $87.20M $87.37M
Total Long-Term Assets $18.70M $10.44M $31.57M
Total Assets $113.7M $97.64M $118.9M
YoY Change 16.5% -12.23% 18.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.70M $11.28M $13.32M
YoY Change 12.39% 61.08% 129.47%
Accrued Expenses $34.60M $23.30M $22.90M
YoY Change 30.57% -13.22% 3.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $500.0K
YoY Change
Total Short-Term Liabilities $58.60M $47.62M $45.16M
YoY Change 23.11% 9.95% 22.7%
LONG-TERM LIABILITIES
Long-Term Debt $600.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.600M $140.0K $640.0K
YoY Change 138.89% -69.57% 26.73%
Total Long-Term Liabilities $9.200M $140.0K $640.0K
YoY Change 155.56% -69.57% 26.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.60M $47.62M $45.16M
Total Long-Term Liabilities $9.200M $140.0K $640.0K
Total Liabilities $67.80M $51.25M $48.54M
YoY Change 32.16% 10.59% 23.08%
SHAREHOLDERS EQUITY
Retained Earnings -$24.01M $2.283M
YoY Change -914.73% -111.45%
Common Stock $70.47M $68.19M
YoY Change 13.58% -16.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.90M $46.39M $70.40M
YoY Change
Total Liabilities & Shareholders Equity $113.7M $97.64M $118.9M
YoY Change 16.5% -12.23% 18.17%

Cashflow Statement

Concept 2019 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$12.35M -$26.29M -$873.0K
YoY Change -59.87% -214.92% -114.11%
Depreciation, Depletion And Amortization $1.500M $360.0K $310.0K
YoY Change 24.07% 33.33% 19.23%
Cash From Operating Activities -$2.217M $8.430M -$1.620M
YoY Change -819.81% 26.2% -143.55%
INVESTING ACTIVITIES
Capital Expenditures $991.0K -$280.0K -$630.0K
YoY Change -33.4% -33.33% 173.91%
Acquisitions
YoY Change
Other Investing Activities $2.060M -$4.490M $5.560M
YoY Change -83.2% -132.33% -614.81%
Cash From Investing Activities $1.067M -$4.760M $4.920M
YoY Change -90.1% -135.34% -475.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.414M 520.0K 130.0K
YoY Change 79.67% -102.51% -102.06%
NET CHANGE
Cash From Operating Activities -$2.217M 8.430M -1.620M
Cash From Investing Activities $1.067M -4.760M 4.920M
Cash From Financing Activities $1.414M 520.0K 130.0K
Net Change In Cash $264.0K 4.190M 3.430M
YoY Change -97.78% -798.33% -188.17%
FREE CASH FLOW
Cash From Operating Activities -$2.217M $8.430M -$1.620M
Capital Expenditures $991.0K -$280.0K -$630.0K
Free Cash Flow -$3.208M $8.710M -$990.0K
YoY Change 171.86% 22.68% -125.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2019Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
CY2018Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000
CY2019Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
7605000
CY2018Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
9532000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
7605000
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
738000
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
610000
CY2017 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
365000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
1015000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
576000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
152000
CY2018Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
287000
CY2019Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
4600000
CY2018Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
5200000
CY2019Q4 us-gaap Cash
Cash
20005000
CY2018Q4 us-gaap Cash
Cash
21969000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26316000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26052000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14184000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13775000
CY2019Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
26316000
CY2018Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
26052000
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
264000
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11868000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
409000
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
26316000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
26052000
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14315586
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14315586
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13968852
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13968852
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Comparability</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company adopted the new revenue standard effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018, </div>using the modified retrospective method. Prior period financial statements were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> retrospectively restated. The financial results for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> reflect the adoption of this accounting standard whereas financial results for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>were prepared using prior revenue recognition guidance.&nbsp; As a result the consolidated statements of operations for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> directly comparable to the consolidated statement of operations for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company adopted the new lease standard effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2019, </div>using the modified retrospective method. Prior period financial statements were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> retrospectively restated. The financial results for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>were prepared using the new lease accounting standard whereas the financial results for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> were prepared using prior effective guidance.&nbsp; As a result the consolidated balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> directly comparable to the balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>and the consolidated statement of operations for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,2019</div> is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> directly comparable to the consolidated statements of operations for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29973000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12339000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30747000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company&#x2019;s operating results.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company is also subject to risks related to changes in the value of the Company&#x2019;s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments and accounts receivable. The Company&#x2019;s cash and cash equivalents are primarily invested in deposits and money market accounts with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed the amount of insurance provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on its deposits of cash and cash equivalents.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company invests in debt instruments, including bonds of the U.S. Government, its agencies and municipalities. The Company has also invested in other high grade investments such as commercial paper and corporate debt securities. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. By policy, the Company restricts its exposure to any single issuer by imposing concentration limits. To minimize the exposure due to adverse shifts in interest rates, the Company maintains investments at an average maturity of generally less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Accounts receivable are recorded net of an allowance for doubtful accounts, and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains reserves for potential credit losses. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div>customer represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the Company&#x2019;s net accounts receivable. During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> domestic revenue accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">58%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62%,</div> , respectively, of total revenue, while international revenue accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">42%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38%,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">38%,respectively,</div> of total revenue. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> single customer represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue for any of the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Supplier concentration</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The Company relies on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> parties for the supply of components of its products, as well as <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party logistics providers. In instances where these parties fail to perform their obligations, the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> supplier for its <div style="display: inline; font-style: italic;">Secret</div> product.</div></div></div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83549000
CY2019Q4 us-gaap Cost Of Revenue
CostOfRevenue
23005000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14222000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6021
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
82338000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5767000
CY2018Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11656000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12566000
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11656000
CY2017 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65383000
CY2018Q4 us-gaap Cost Of Revenue
CostOfRevenue
26683000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
19884000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
21943000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
18717000
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
18688000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
20176000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
16791000
CY2019Q4 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
2527000
CY2018Q4 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
2379000
CY2019Q4 cutr Available For Sale Securities Debt Maturities Year Two Through Three Fair Value
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
CY2019Q4 cutr Capital Stock Shares Authorized
CapitalStockSharesAuthorized
55000000
CY2019Q4 cutr Cash And Cash Equivalents And Marketable Investments Fair Market Value
CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue
33921000
CY2018Q4 cutr Cash And Cash Equivalents And Marketable Investments Fair Market Value
CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue
35575000
CY2019Q4 cutr Cash Cash Equivalents And Marketable Investments Amortized Cost
CashCashEquivalentsAndMarketableInvestmentsAmortizedCost
33921000
CY2018Q4 cutr Cash Cash Equivalents And Marketable Investments Amortized Cost
CashCashEquivalentsAndMarketableInvestmentsAmortizedCost
35584000
CY2019 cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
9451000
CY2018 cutr Contract With Customer Liability Decrease From Revenue Deferred
ContractWithCustomerLiabilityDecreaseFromRevenueDeferred
8206000
CY2019 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
17127000
CY2018 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
14883000
CY2019 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
9300000
CY2018 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
7800000
CY2017 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
6000000
CY2019Q4 cutr Deferred Tax Assets Foreign
DeferredTaxAssetsForeign
CY2018Q4 cutr Deferred Tax Assets Foreign
DeferredTaxAssetsForeign
457000
CY2019Q4 cutr Deferred Tax Assets Operating Lease Asset
DeferredTaxAssetsOperatingLeaseAsset
3949000
CY2018Q4 cutr Deferred Tax Assets Operating Lease Asset
DeferredTaxAssetsOperatingLeaseAsset
CY2019Q4 cutr Deferred Tax Liabilities Accrued Commissions606 Cost
DeferredTaxLiabilitiesAccruedCommissions606Cost
1076000
CY2018Q4 cutr Deferred Tax Liabilities Accrued Commissions606 Cost
DeferredTaxLiabilitiesAccruedCommissions606Cost
1269000
CY2019 cutr Depreciation And Amortization Excluding Contract Acquisition Costs
DepreciationAndAmortizationExcludingContractAcquisitionCosts
1548000
CY2019 cutr Lease Termination Expense Income
LeaseTerminationExpenseIncome
CY2018 cutr Lease Termination Expense Income
LeaseTerminationExpenseIncome
CY2018 cutr Depreciation And Amortization Excluding Contract Acquisition Costs
DepreciationAndAmortizationExcludingContractAcquisitionCosts
1209000
CY2017 cutr Depreciation And Amortization Excluding Contract Acquisition Costs
DepreciationAndAmortizationExcludingContractAcquisitionCosts
1016000
CY2019 cutr Effective Income Tax Rate Reconciliation Deferred Trueup Percent
EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
0.0571
CY2018 cutr Effective Income Tax Rate Reconciliation Deferred Trueup Percent
EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
CY2017 cutr Effective Income Tax Rate Reconciliation Deferred Trueup Percent
EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent
CY2019 cutr Effective Income Tax Rate Reconciliation Meals And Entertainment Percent
EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
-0.0283
CY2018 cutr Effective Income Tax Rate Reconciliation Meals And Entertainment Percent
EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
-0.0266
CY2017 cutr Effective Income Tax Rate Reconciliation Meals And Entertainment Percent
EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent
0.0215
CY2019 cutr Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.0258
CY2018 cutr Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
CY2017 cutr Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
CY2019 cutr Effective Income Tax Rate Reconciliation Research And Development Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
0.0814
CY2018 cutr Effective Income Tax Rate Reconciliation Research And Development Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
0.0431
CY2017 cutr Effective Income Tax Rate Reconciliation Research And Development Percent
EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent
-0.0272
CY2019 cutr Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
CY2018 cutr Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
-0.0243
CY2017 cutr Effective Income Tax Rate Reconciliation Return To Provision Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent
CY2019 cutr Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
-0.386
CY2018 cutr Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
-1.5549
CY2017 cutr Effective Income Tax Rate Reconciliation Valuation Allowance Percent
EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
-2.1817
CY2019 cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
-1160000
CY2018 cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
3159000
CY2017 cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
CY2019Q4 cutr Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
6002000
CY2018Q4 cutr Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
6002000
CY2019Q4 cutr Lease Rightofuse Asset
LeaseRightofuseAsset
8710000
CY2017 cutr Lease Termination Expense Income
LeaseTerminationExpenseIncome
-4000000
CY2019 cutr Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net
ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet
3900000
CY2018 cutr Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net
ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet
1300000
CY2017 cutr Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net
ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet
4000000
CY2017 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
258.935
CY2018 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
148197
CY2019 cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
407320
CY2017 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
873881
CY2018 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
562070
CY2019 cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
1538128
CY2017 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved
1600000
CY2019 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved
700000
CY2017 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
278250
CY2018 cutr Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted
ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted
21010
CY2019Q4 cutr Total Cash Cash Equivalents And Marketable Securities
TotalCashCashEquivalentsAndMarketableSecurities
33921000
CY2018Q4 cutr Total Cash Cash Equivalents And Marketable Securities
TotalCashCashEquivalentsAndMarketableSecurities
35575000
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001162461
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14416483
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
418000000
CY2019 dei Entity Registrant Name
EntityRegistrantName
CUTERA INC
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Security12b Title
Security12bTitle
Common Stock ($0.001 par value)
CY2019 dei Trading Symbol
TradingSymbol
cutr
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12685000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11279000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21556000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19637000
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
93000
CY2018Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
394000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30307000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23300000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14341000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9377000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8965000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8127000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82346000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
70451000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2915000
CY2018 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1834000
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
CY2019 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
800000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7157000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9832000
CY2018 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3100000
CY2017 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1500000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5110000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
2800000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
2800000
CY2017 us-gaap Advertising Expense
AdvertisingExpense
1800000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9832000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7157000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5110000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1355000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1257000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1265000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1272000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000
CY2019Q4 us-gaap Assets
Assets
113738000
CY2018Q4 us-gaap Assets
Assets
97637000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
95046000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
87198000
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
7605000
CY2018Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
9523000
CY2016Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
3813000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-15000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
148000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-76000
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
303000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
511000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
25000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
411000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
730000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
101000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
123000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
71000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2018 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-9000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
15674000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-17393000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
57000
CY2018 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-60000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-22000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
423000
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
457000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
60000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16844000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-18763000
CY2018Q4 us-gaap Deferred Revenue
DeferredRevenue
12566000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10831000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9882000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3391000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2684000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1230000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14507000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11227000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5482000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1809000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1348000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
37831000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29674000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
424000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
457000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1111000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1040000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
2202000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.16
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
897000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
282000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2354000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2024000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
11888000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10857000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
1924000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
924000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
1863000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32350000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
27865000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
97000
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
83000
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3885000
CY2018Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2019 us-gaap Depreciation
Depreciation
1500000
CY2018 us-gaap Depreciation
Depreciation
1200000
CY2017 us-gaap Depreciation
Depreciation
1000000
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.89
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.23
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.89
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.23
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.04
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.6098
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.007
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.2766
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.5075
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0034
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0011
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0378
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.1366
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.2155
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0033
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0121
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0065
CY2019 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.0253
CY2018 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
CY2017 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0282
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0495
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0559
CY2018Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
3159000
CY2019Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
1999000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
88000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
88000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1119000
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1212000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
543000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
4000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
253000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
412000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
93000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
649000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
704000
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.056
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y182D
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4663000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4663000
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5933000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7308000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5267000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5525000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5494000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5160000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4902000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5439000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24033000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20995000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14090000
CY2019Q4 us-gaap Goodwill
Goodwill
1339000
CY2018Q4 us-gaap Goodwill
Goodwill
1339000
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
1339000
CY2018Q4 us-gaap Goodwill Gross
GoodwillGross
1339000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q4 us-gaap Gross Profit
GrossProfit
28790000
CY2019Q3 us-gaap Gross Profit
GrossProfit
26233000
CY2019Q2 us-gaap Gross Profit
GrossProfit
25831000
CY2019Q1 us-gaap Gross Profit
GrossProfit
17309000
CY2018Q4 us-gaap Gross Profit
GrossProfit
18786000
CY2018Q3 us-gaap Gross Profit
GrossProfit
21885000
CY2018Q2 us-gaap Gross Profit
GrossProfit
22377000
CY2018Q1 us-gaap Gross Profit
GrossProfit
17334000
CY2019 us-gaap Gross Profit
GrossProfit
98163000
CY2018 us-gaap Gross Profit
GrossProfit
80382000
CY2017 us-gaap Gross Profit
GrossProfit
86110000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-13037000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-14177000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
11203000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
774000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
662000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
757000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1949000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2555000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
345000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8105000
CY2018Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5534000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1047000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2284000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4651000
CY2017 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
18678000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1656000
CY2018 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-17438000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-12263000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13515000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11960000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
139000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-243000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000
CY2018Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20760000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-174000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-712000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2619000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17255000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18033000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
59000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
472000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
220000
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1406000
CY2018 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4277000
CY2017 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4404000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2509000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
117000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4229000
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-301000
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
211000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7157000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3781000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9345000
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-34000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1305000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1557000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5907000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-768000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13805000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3355000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2754000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-6000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-140000
CY2018 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
140000
CY2017 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1762000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1070000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
591000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1339000
CY2018Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1339000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
81000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
85000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
70000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4100000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2900000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13970000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8717000
CY2019Q4 us-gaap Inventory Net
InventoryNet
33921000
CY2018Q4 us-gaap Inventory Net
InventoryNet
28014000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17935000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16991000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2500000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1800000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2016000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2306000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8654000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2868000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
26000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
326000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2821000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2613000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
742000
CY2019Q4 us-gaap Liabilities
Liabilities
67796000
CY2018Q4 us-gaap Liabilities
Liabilities
51251000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113738000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97637000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58622000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
47620000
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
CY2018Q4 us-gaap Litigation Reserve
LitigationReserve
171000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7605000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8026000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
9523000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1414000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
787000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31572000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1067000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10773000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17694000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2217000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
308000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14287000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-2088000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2628000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
588000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-8220000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-26293000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-873000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1572000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2032000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-12348000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-30770000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
29993000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-79000
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-129000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
98000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-199000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-123000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
884000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019 us-gaap Open Tax Year
OpenTaxYear
2011 2012 2013 2014 2015 2016 2017 2018
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
30719000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
28642000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
25532000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
25335000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
24276000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
22883000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
24532000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
22083000
CY2019 us-gaap Operating Expenses
OperatingExpenses
110227000
CY2018 us-gaap Operating Expenses
OperatingExpenses
93774000
CY2017 us-gaap Operating Expenses
OperatingExpenses
75034000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1929000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10049000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11223000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3011000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2495000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2564000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2409000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2939000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
214000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7912000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5116000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
299000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3943000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
12687000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5490000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-998000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2155000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2800000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6411000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5971000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
9000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2430000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
14000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10874000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4749000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-12064000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-13392000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
11076000
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
2892000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5112000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7759000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2820000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7702000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-15000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
9000
CY2018 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
23000
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-20000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
23000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20000
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
CY2018 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-9000
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
5000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
578000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
553000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
127000
CY2018 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
241000
CY2017 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-51000
CY2019 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2018 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2017 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
35167000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
831000
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3129000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1469000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
4399000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5435000
CY2019 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14700000
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
60956000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
991000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1488000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
855000
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5648000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3972000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2894000
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1000
CY2019Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
10050000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
45812000
CY2019 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
CY2018 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
13044000
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
33640000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
41000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
53000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4401000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4666000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11782000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10799000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2817000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2672000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
590000
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1257000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
649000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
483000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
371000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4463000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3643000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3273000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3706000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3464000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3244000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4095000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3556000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15085000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14359000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12874000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36358000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24010000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
181712000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
162720000
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
151493000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14200000
CY2019Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.76
CY2019Q4 us-gaap Revenues
Revenues
51795000
CY2019Q3 us-gaap Revenues
Revenues
46117000
CY2019Q2 us-gaap Revenues
Revenues
47774000
CY2019Q1 us-gaap Revenues
Revenues
36026000
CY2018Q4 us-gaap Revenues
Revenues
45469000
CY2018Q3 us-gaap Revenues
Revenues
40573000
CY2018Q2 us-gaap Revenues
Revenues
42553000
CY2018Q1 us-gaap Revenues
Revenues
34125000
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3922000
CY2018Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2935000
CY2019Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20323000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17691000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16992000
CY2019Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16104000
CY2018Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15318000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14479000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15535000
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13088000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
71109000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
58420000
CY2017 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52070000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9832000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7157000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
5110000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
721657
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1494866
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1141305
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
761705
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
222400
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.16
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8300000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8000000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
66405
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
81322
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
51208
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
16.54
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2155
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
24.61
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
278250
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
21010
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8700000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
24400000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2000000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3040000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1116472
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
839919
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
507705
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
295699
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.56
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.46
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.52
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.52
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3060000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
285462
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
25.08
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.96
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.99
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.03
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
31
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
50.65
CY2019Q4 us-gaap Share Price
SharePrice
35.81
CY2018Q4 us-gaap Share Price
SharePrice
17.02
CY2017Q4 us-gaap Share Price
SharePrice
45.35
CY2016Q4 us-gaap Share Price
SharePrice
17.35
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3040000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y302D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y255D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y361D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y189D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y69D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
42695
CY2018 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
77049
CY2017 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
64490
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7827000
CY2017Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3508000
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6400000
CY2019 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
7894000
CY2018 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
8045000
CY2019 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
6467000
CY2018 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
12364000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
488398
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
271902
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
160798
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1059000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1680000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1281000
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1469000
CY2018 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3128000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-831000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4376000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2718000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1613000
CY2017 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
35166000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45942000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
46386000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
61010000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
64893000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14086000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1563000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1519000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
707000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1426000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
291000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
70000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
58000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
129000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
114000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
169000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
643000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
25000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of Consolidated Financial Statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, accounts receivable and allowance for credit losses, valuation of inventories, fair value of goodwill, useful lives of property and equipment, incremental borrowing rates related to the Company&#x2019;s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, fair value of investments, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contracts acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div></div></div></div></div></div></div></div></div></div></div>
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4500000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
20600000
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2018 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14728000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14261000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14182000
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
855000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14261000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14182000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14356000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14017000
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13932000
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13851000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13709000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13587000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14096000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13771000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14017000
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13932000
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13851000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13709000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13587000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14096000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13771000
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13873000

Files In Submission

Name View Source Status
0001437749-20-005342-index-headers.html Edgar Link pending
0001437749-20-005342-index.html Edgar Link pending
0001437749-20-005342.txt Edgar Link pending
0001437749-20-005342-xbrl.zip Edgar Link pending
cutr-20191231.xml Edgar Link completed
cutr-20191231.xsd Edgar Link pending
cutr-20191231_cal.xml Edgar Link unprocessable
cutr-20191231_def.xml Edgar Link unprocessable
cutr-20191231_lab.xml Edgar Link unprocessable
cutr-20191231_pre.xml Edgar Link unprocessable
cutr20191231_10k.htm Edgar Link pending
ex_176256.htm Edgar Link pending
ex_176257.htm Edgar Link pending
ex_176258.htm Edgar Link pending
ex_176259.htm Edgar Link pending
ex_177316.htm Edgar Link pending
ex_177317.htm Edgar Link pending
ex_177322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
graph01.jpg Edgar Link pending
img01.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending